Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$2.21 USD
-0.05 (-2.21%)
Updated May 24, 2024 03:27 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 37.50% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.30 |
Next Year | -2.53 |
EPS (TTM) | -1.84 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.33M | 0.00M | 0.80M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.53 | -2.30 | -2.53 |
# of Estimates | 2 | 2 | 4 | 4 |
Most Recent Consensus | -0.54 | -0.57 | -2.08 | -1.93 |
High Estimate | -0.46 | -0.48 | -1.84 | -1.93 |
Low Estimate | -0.54 | -0.57 | -2.97 | -3.31 |
Year ago EPS | -0.62 | -0.37 | -1.91 | -2.30 |
Year over Year Growth Est. | 19.35% | -43.24% | -20.42% | -9.89% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 3 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.53 | -2.30 | -2.53 |
7 Days Ago | -0.50 | -0.53 | -2.30 | -2.53 |
30 Days Ago | -0.63 | -0.64 | -2.60 | -2.93 |
60 Days Ago | -0.63 | -0.64 | -2.83 | -3.20 |
90 Days Ago | -0.62 | -0.63 | -2.82 | -3.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.53 | -2.08 | -2.27 |
Zacks Consensus Estimate | -0.50 | -0.53 | -2.30 | -2.53 |
Earnings ESP | 0.00% | 0.00% | 9.66% | 10.28% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.45 | -0.37 | -0.62 | NA |
Estimate | -0.64 | -0.55 | -0.62 | -0.59 | NA |
Difference | 0.24 | 0.10 | 0.25 | -0.03 | 0.14 |
Surprise | 37.50% | 18.18% | 40.32% | -5.08% | 22.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more